Potential Carbon Savings with Day-case Compared to Inpatient Transurethral Resection of Bladder Tumour Surgery in England: A Retrospective Observational Study Using Administrative Data.
Carbon footprint
Day case
Sustainable health care
Transurethral resection of bladder tumour
Urology
Journal
European urology open science
ISSN: 2666-1683
Titre abrégé: Eur Urol Open Sci
Pays: Netherlands
ID NLM: 101771568
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
accepted:
29
03
2023
medline:
7
6
2023
pubmed:
7
6
2023
entrez:
7
6
2023
Statut:
epublish
Résumé
The National Health Service (NHS) in England has set a net-zero target for carbon emissions by 2040. Increasing use of day-case surgery pathways may help in meeting this target. To investigate the estimated difference in carbon footprint between day-case and inpatient transurethral resection of bladder tumour (TURBT) surgery in England. This was a retrospective analysis of administrative data extracted from the Hospital Episode Statistics database for all TURBT procedures conducted in England from April 1, 2013 to March 31, 2022. Day-case and inpatient TURBT procedures were identified and the carbon footprint for key elements of the surgical pathway was estimated using data from Greener NHS and the Sustainable Healthcare Coalition. Of 209 269 TURBT procedures identified, 41 583 (20%) were classified as day-case surgery. The day-case rate increased from 13% in 2013-2014 to 31% in 2021-2022. The move from inpatient stays to day-case surgery between 2013-2014 and 2021-2022 demonstrates a trend toward a lower-carbon pathway, with an estimated saving of 2.9 million kg CO Our study highlights potential NHS carbon savings that could be achieved by moving from inpatient stays to day-case surgery. Reducing variation in care across the NHS and encouraging all hospitals to adopt day-case surgeries, where clinically appropriate, would lead to further carbon savings. In this study we estimated the potential for carbon savings if patient undergoing bladder tumour surgery were admitted and discharged on the same day. We estimate that increasing use of day-case surgery between 2013-2014 and 2021-2022 has saved 2.9 million kg CO
Sections du résumé
Background
UNASSIGNED
The National Health Service (NHS) in England has set a net-zero target for carbon emissions by 2040. Increasing use of day-case surgery pathways may help in meeting this target.
Objective
UNASSIGNED
To investigate the estimated difference in carbon footprint between day-case and inpatient transurethral resection of bladder tumour (TURBT) surgery in England.
Design setting and participants
UNASSIGNED
This was a retrospective analysis of administrative data extracted from the Hospital Episode Statistics database for all TURBT procedures conducted in England from April 1, 2013 to March 31, 2022.
Outcome measurements and statistical analysis
UNASSIGNED
Day-case and inpatient TURBT procedures were identified and the carbon footprint for key elements of the surgical pathway was estimated using data from Greener NHS and the Sustainable Healthcare Coalition.
Results and limitations
UNASSIGNED
Of 209 269 TURBT procedures identified, 41 583 (20%) were classified as day-case surgery. The day-case rate increased from 13% in 2013-2014 to 31% in 2021-2022. The move from inpatient stays to day-case surgery between 2013-2014 and 2021-2022 demonstrates a trend toward a lower-carbon pathway, with an estimated saving of 2.9 million kg CO
Conclusions
UNASSIGNED
Our study highlights potential NHS carbon savings that could be achieved by moving from inpatient stays to day-case surgery. Reducing variation in care across the NHS and encouraging all hospitals to adopt day-case surgeries, where clinically appropriate, would lead to further carbon savings.
Patient summary
UNASSIGNED
In this study we estimated the potential for carbon savings if patient undergoing bladder tumour surgery were admitted and discharged on the same day. We estimate that increasing use of day-case surgery between 2013-2014 and 2021-2022 has saved 2.9 million kg CO
Identifiants
pubmed: 37284039
doi: 10.1016/j.euros.2023.03.007
pii: S2666-1683(23)00188-X
pmc: PMC10240513
doi:
Types de publication
Journal Article
Langues
eng
Pagination
44-50Informations de copyright
© 2023 The Authors.
Références
Lancet. 2022 Nov 5;400(10363):1619-1654
pubmed: 36306815
Lancet Planet Health. 2017 Dec;1(9):e381-e388
pubmed: 29851650
Global Spine J. 2022 Oct 1;:21925682221131764
pubmed: 36189915
Eur Arch Otorhinolaryngol. 2017 Jan;274(1):305-310
pubmed: 27535844
Cancer Treat Res Commun. 2021;27:100369
pubmed: 33838570
J Laryngol Otol. 2021 Apr;135(4):341-343
pubmed: 33766165
J Urol. 2007 Oct;178(4 Pt 1):1201-5; discussion 1205
pubmed: 17698090
Lancet. 2018 May 5;391(10132):1775-1782
pubmed: 29706364
Eur Urol Focus. 2022 Jan;8(1):141-151
pubmed: 33602641
Lancet Planet Health. 2021 Feb;5(2):e66-e68
pubmed: 33581064
Lancet Planet Health. 2021 Feb;5(2):e84-e92
pubmed: 33581070
Anaesthesia. 2022 Mar;77(3):277-285
pubmed: 34530496